How to reconstitute lyophilized peptides in the lab: solvent choice, stock solutions, storage and troubleshooting

Scope: this is a laboratory guide for in-vitro and analytical work: making stock solutions for assays, HPLC or LC-MS standards, and cell-based experiments. It does not cover, and must not be used for, preparing anything for human or animal administration. Research peptides are for laboratory research use only.

Reconstitution turns a lyophilized peptide back into a solution of known concentration. It looks like the easiest step in an experiment, yet many unexplained results start here: a peptide that never fully dissolved, a concentration calculated on the wrong mass, a solvent that quietly damaged the sequence, or a stock that lost half its peptide to the tube wall. This guide works through the decisions in order, with the evidence behind each one. For what the dry cake is and how it is made, see what is a lyophilized peptide.

Before you start: what is actually in the vial?

A vial labelled with a peptide mass rarely contains that mass of pure peptide. Three things share the powder:

• The peptide itself.
• Counter-ions. Peptides with basic or acidic groups are usually isolated as salts. EMA notes that acetate is the usual counter-ion for synthetic peptides, “however, other counter-ions are also possible (e.g. trifluoroacetate or chloride)” [1]. Trifluoroacetate (TFA) can remain “either directly bonded with basic residues of peptides or adsorbed in lyophilizate as a contaminant” [2].
• Water. EMA warns that “peptides are often very hygroscopic powders” and that moisture content should be confirmed before use for reference standards [1].

For this reason EMA expects peptide assay values to be “expressed in terms of the counter-ion free, anhydrous substance” [1]. In the lab, the equivalent figure is the net peptide content on the certificate of analysis. Use it, not the gross weight, when calculating concentration.

The counter-ion can also matter biologically. Cornish and colleagues found that TFA at 10⁻⁸ to 10⁻⁷ M reduced cell numbers in fetal rat osteoblast cultures, and that TFA salts of three peptides consistently gave less cell proliferation than their hydrochloride salts, enough to hide a real effect or create a false one [3]. If you run cell-based assays, check which salt you have and consider an acetate or hydrochloride form.

Equipment checklist

Item	Why
Certificate of analysis for the exact lot	Net peptide content, counter-ion, molecular weight, purity
Desiccator or sealed box with desiccant	Peptides are often hygroscopic [1]; lets a cold vial warm without condensation
Calibrated micropipettes and low-retention tips	Accurate volumes at small scale
Low-binding tubes, chosen for the peptide	Peptides adsorb differently to different plastics and glass [10]
Solvents: water or assay buffer, dilute acetic acid, dilute ammonium bicarbonate or ammonia, DMSO or acetonitrile	The solvent ladder below
pH paper or a micro pH probe	Confirms the pH you think you have
0.22 µm sterilising-grade filter unit (only if sterility is needed)	Removes microorganisms; check recovery [12] [13]
Biosafety cabinet or clean bench, as your risk assessment specifies	Aseptic handling for cell work
Freezer-proof labels	Lot, solvent, concentration, date, initials

How do you choose a solvent from the peptide sequence?

Start by reading the sequence, not by reaching for DMSO. Two properties predict most of what will happen: net charge at the pH you plan to use, and hydrophobicity.

Step 1: estimate net charge

Count the ionisable groups. Sikora and colleagues summarise them: the side chains of aspartic acid and glutamic acid and the C-terminal carboxyl are anionic, while histidine, lysine, arginine and the N-terminal amino group are basic; cysteine and tyrosine side chains can also ionise, but with pKa values of 8.14 and 10.10 they are mostly protonated at physiological pH [2].

A practical screen:

1. Give +1 for each Lys and Arg, and for a free N-terminus.
2. Give −1 for each Asp and Glu, and for a free C-terminus.
3. Treat His as uncertain: it is only partly protonated near neutral pH, so its contribution depends on the pH you choose.
4. Skip the terminus that is blocked (C-terminal amide, N-terminal acetyl).

A positive total means a basic peptide, a negative total an acidic peptide, and a total near zero a neutral one. This is a screen, not an exact charge calculation: real pKa values shift with the local environment, as Sikora’s review explains [2].

Step 2: judge hydrophobicity

Look at the share of hydrophobic residues (Ile, Val, Leu, Phe, Met, Trp, Ala, Cys) and whether they cluster. Kyte and Doolittle’s hydropathy scale is the classic way to score this residue by residue [4]. As a working rule, a neutral peptide with a high share of hydrophobic residues, or a long hydrophobic stretch, is likely to need an organic co-solvent.

Not all hydrophilic residues help equally. In studies of solubility-changing mutations reviewed by Trevino and colleagues, aspartic acid, glutamic acid and serine contributed “significantly more favorably to protein solubility” than asparagine, glutamine, threonine, lysine and arginine [5]. A peptide rich in Gln and Asn may be harder to dissolve than its polarity suggests.

Step 3: pick from the solvent ladder

Use the mildest step that works, and test it on a small portion before committing the whole lot.

Peptide type	Try first	If it does not dissolve	Watch for
Short or highly charged	Water or assay buffer	More volume, then gentle mixing	Salts added too early can reduce solubility
Basic (net positive)	Water	A small volume of dilute acetic acid, then dilute to final volume	Final acid level must suit the assay
Acidic (net negative)	Water or buffer	A small volume of dilute ammonium bicarbonate or ammonia, then dilute	Avoid high pH with free Cys: its thiol (pKa 8.14) ionises above about pH 8 [2]
Neutral, hydrophobic	A minimal volume of DMSO, DMF or acetonitrile	Add water or buffer slowly, dropwise, with mixing	DMSO oxidises Cys thiols [8]; solvent limits in cell assays [9]
Contains Cys, Met or Trp	Degassed water or acidic buffer	DMF or acetonitrile in place of DMSO for Cys	Oxidation; minimise headspace and time open
Long or aggregation-prone	Dissolve at low concentration first	Concentrate later if needed	Aggregation depends on concentration, pH and agitation [7]

Two cautions on pH. The rule of thumb is to move pH away from the point where the peptide carries no net charge, because charge repulsion keeps molecules apart. It is a heuristic, not a law: Dumetz and colleagues found that, for the proteins they studied under salting-out conditions, “neither aggregate nor crystal solubility had a minimum at the isoelectric point” [6]. And small pH changes can change aggregation behaviour qualitatively: for native GLP-1, Zapadka and colleagues observed a “highly unusual pH-induced switch” in fibril-formation kinetics between pH 7.5 and 8.2 [22].

DMSO, DMF and acetonitrile: when and how much

Organic co-solvents dissolve hydrophobic peptides well, but they bring their own chemistry and biology:

• Thiol oxidation. DMSO oxidises cysteine thiols; Liu and colleagues used it deliberately to form disulfide-linked dimers of Cys-containing peptides and reported “highly oxidized side products”; dimer and side-product formation depended on cysteine position, and hydrophobic residues slowed oxidation by shielding the thiol [8]. If your peptide has a free Cys, DMSO is a reagent, not an inert solvent.
• Cell effects. Timm and colleagues found that DMSO “above 1 % reduces readout parameters in all cell types”, while 0.25% and 0.5% had inhibitory effects in some cell types and stimulatory effects in others; they recommend keeping solvent concentration constant across serial dilutions [9]. Dissolve in the smallest volume of co-solvent that works, then dilute, and include a vehicle control at the same final solvent level.

How do you make a peptide stock solution? (worked example)

The arithmetic is simple once you use net peptide content. The example below is for an in-vitro assay stock. Values are illustrative and not specific to any product.

Inputs from the certificate (hypothetical lot):

• Gross powder weighed on an analytical balance: 2.0 mg
• Net peptide content: 80%
• Molecular weight (peptide, free base): 1,250 g/mol

1. Net peptide mass. 2.0 mg × 0.80 = 1.6 mg peptide.

2. Amount of peptide. 1.6 mg ÷ 1,250 g/mol = 1.28 µmol.

3. Volume for a 1.0 mM stock. 1.0 mM is 1.0 µmol per mL, so 1.28 µmol ÷ 1.0 µmol/mL = 1.28 mL total, including any co-solvent added first.

4. A working solution for the assay. For 1.0 mL of 10 µM in assay buffer: C₁V₁ = C₂V₂, so V₁ = (10 µM × 1,000 µL) ÷ 1,000 µM = 10 µL of stock plus 990 µL of buffer.

If the first 10% of the volume is DMSO (128 µL of the 1.28 mL), the stock is 10% DMSO, and the 10 µL in 1.0 mL above leaves 0.1% DMSO in the well. Run the vehicle control at that level [9].

Step-by-step method

1. Equilibrate. Take the closed vial out of the freezer and let it reach room temperature, ideally in a desiccator, before opening. Peptides are often very hygroscopic [1], and a cold vial opened in room air collects condensation.
2. Collect the powder. Tap the closed vial, or spin briefly in a compatible holder, so the solid sits at the bottom.
3. Prepare the workspace. Clean the bench; set out tips, tubes and solvents.
4. Add the first solvent down the wall. Pipette slowly against the inside wall, not onto the cake, to avoid foaming.
5. Mix gently. Swirl, invert or pipette slowly. Agitation is among the physical factors reviewed as influencing peptide aggregation [7].
6. Inspect. Hold the vial against light and dark backgrounds. A complete solution is clear, without flakes or film. If not, see troubleshooting below.
7. Dilute to final volume with water or buffer, adding buffer salts last.
8. Verify, if the result matters. UV absorbance (for Trp- or Tyr-containing sequences) or HPLC against a reference gives the real concentration.
9. Aliquot, label, freeze. See storage below.

Bacteriostatic water vs sterile water: do they belong in a lab?

These two products come up constantly in searches about peptides, so it is worth being precise. Both are regulated pharmaceutical products, not laboratory reagents, and their clinical use is outside the scope of this guide. The only question here is whether they make sense as solvents for in-vitro or analytical work. Usually they do not.

	Bacteriostatic Water for Injection, USP	Sterile Water for Injection, USP
What it contains (US label examples)	Water with benzyl alcohol “added as a bacteriostatic preservative” [17]	Water that “contains no bacteriostat, antimicrobial agent or added buffer” [18]
What it adds to your sample	Benzyl alcohol	Nothing
Known effect on proteins	Reconstituting a lyophilized protein with 0.9% (w/v) benzyl alcohol caused more aggregation than reconstitution with water [19]	None from additives
Lab suitability	Usually avoid: the preservative is an uncontrolled variable in assays and spectra	Not made as a laboratory reagent; laboratory water of a specified grade is usually simpler and better documented

In regulatory terms, EMA defines water for injections as water for preparing medicines for parenteral administration, and purified water as water for medicines that do not need to be both sterile and apyrogenic [20]. Neither definition describes a laboratory solvent. For analytical and in-vitro work, what you need is water whose quality matches the method: chromatography-grade water for HPLC and LC-MS, and sterile, endotoxin-tested water or medium for cell culture. A preservative is rarely something you want in an experiment.

Why won’t my peptide dissolve? Troubleshooting table

What you see	Likely cause	What to try (on a small test portion)
Powder floats or stays as flakes in water	Hydrophobic or neutral sequence	Restart with a minimal volume of organic co-solvent, then dilute slowly
Dissolves, then clouds when buffer is added	Salting out, or pH moved towards zero net charge	Dissolve fully in water or dilute acid or base first; add buffer last and slowly
Gel or viscous solution	Self-association or fibril formation, often concentration-dependent [7]	Dissolve at lower concentration; avoid shaking
Clear at first, cloudy after hours	Slow aggregation; pH-sensitive kinetics are documented for some peptides [22]	Prepare fresh; change pH or concentration; keep cold
Lower than expected HPLC peak or activity	Adsorption to tube or filter [10] [11] [12]	Change tube material; add a carrier protein if the assay allows; check filter recovery
New peaks at +16 Da or dimer mass by LC-MS	Oxidation of Met, or disulfide formation from Cys, for example in DMSO [8]	Use degassed solvent; avoid DMSO for Cys peptides; reduce time in solution
Concentration consistently lower than expected	Calculated on gross weight instead of net peptide content	Recalculate with net peptide content [1]
Cell response differs between salt forms	Counter-ion effect, for example TFA [3]	Use an acetate or hydrochloride form; include matched controls

Do not heat aggressively or sonicate for long periods to force a stubborn peptide into solution. Temperature is one of the physical factors that promotes peptide aggregation [7], and a solution forced clear can still contain soluble aggregates.

Peptides stick to tubes and filters: how to avoid losing them

Adsorption is easy to overlook because the solution still looks fine. Kristensen and colleagues quantified it by HPLC for three cationic membrane-active peptides and found that “at typical experimental peptide concentrations, 90% or more of the peptides might be lost from solution due to rapid adsorption to the walls of the sample containers” [11]. Goebel-Stengel and colleagues tested eight radiolabelled endocrine peptides across glass and plastic, found “important differences” between surfaces, and showed that siliconisation decreased recovery while 1% bovine serum albumin improved it [10].

Practical steps:

• Choose the tube for the peptide, and test recovery if the work is quantitative [10].
• Keep stocks concentrated and dilute just before use; losses matter most at low concentrations [11].
• Add a carrier protein such as BSA only where the assay tolerates it [10].
• Filter only when needed. Sterile filtration uses a sterilising-grade membrane with a nominal pore size of at most 0.22 µm [13]. Adsorptive loss is “filter- and drug-specific” [12], so measure recovery before and after filtering with your own peptide.

How should reconstituted peptide solutions be stored?

Aliquot once, thaw once

Every freeze-thaw cycle exposes the peptide to the stresses of freezing again. Bhatnagar and colleagues identify “low temperature, freeze-concentration, and ice formation” as the three chief stresses during freezing, and note that freeze-concentration can drive buffer crystallisation, phase separation and faster second-order reactions [15]. Authelin and colleagues stress that frozen-state stability “should not be taken for granted” and that it can depend on sample size, through its effect on cooling rate and freezing time [16].

Divide the stock into single-use aliquots sized for one experiment, and discard what is left after thawing.

Watch the buffer you freeze in

Some buffers change pH dramatically on freezing. Gómez and colleagues measured sodium phosphate solutions during freezing: at an initial pH of 7.4, 50 and 100 mM buffers reached pH 4.2 ± 0.1 at −10 °C, and 8 mM buffer reached pH 5.2 ± 0.2, because disodium phosphate crystallised out [14]. For peptides that are sensitive to acid, avoid freezing in concentrated sodium phosphate, or freeze in water or dilute acid and add buffer after thawing.

Temperature, light and labelling

• Store aliquots frozen, at −20 °C or colder, unless the supplier’s data says otherwise.
• Keep them out of freezer door racks and away from defrost cycles, where temperature swings.
• Protect Trp-, Tyr- and Met-containing peptides from light and minimise headspace for oxidation-prone sequences.
• Label each tube with peptide, lot, solvent, concentration, date and initials.

How long do reconstituted peptides last?

There is no honest single number. The dry form exists precisely because so many peptides are unstable in solution: FDA’s freeze-drying guide notes that products are lyophilized “due to their instability when in solution” [21]. Shelf life in solution depends on sequence, solvent, pH, concentration and temperature. If an experiment depends on a stock older than a few days, generate your own data: run HPLC on an aliquot at time zero and at the age you intend to use it. For the dry powder, storage temperatures and retest dates are covered in lyophilized peptide stability and storage.

Quick reconstitution checklist

• Certificate of analysis for this lot on the bench: net peptide content, counter-ion, molecular weight
• Sequence screened for charge, hydrophobicity, Cys, Met and Trp
• Solvent tested on a small portion first
• Vial warmed to room temperature before opening
• Volume calculated from net peptide mass and target stock concentration
• Mixed gently; solution clear against light and dark backgrounds
• Co-solvent level recorded; vehicle control planned
• Filtered only if sterility is required, with recovery checked
• Single-use aliquots, labelled, frozen

Research peptides from Winhycare Pharma

Winhycare Pharma supplies research-use-only peptides at purity ≥99%, as stated in our brochure, and offers custom peptide synthesis for sequences outside the catalogue. Browse research peptides or send a research peptide enquiry.

For laboratory research use only. Not for human or veterinary use.